Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Highly differentiated cytotoxic T cells in inclusion body myositis.

Greenberg SA, Pinkus JL, Kong SW, Baecher-Allan C, Amato AA, Dorfman DM.

Brain. 2019 Sep 1;142(9):2590-2604. doi: 10.1093/brain/awz207.

PMID:
31326977
2.

Dimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: Implications for the treatment of multiple sclerosis.

von Glehn F, Dias-Carneiro RPC, Moraes AS, Farias AS, Silva VAPG, Oliveira FTM, Silva CEBG, de Carvalho F, Rahal E, Baecher-Allan C, Santos LMB.

Mult Scler Relat Disord. 2018 Jul;23:46-50. doi: 10.1016/j.msard.2018.04.016. Epub 2018 Apr 25. Review.

PMID:
29763776
3.

Multiple Sclerosis: Mechanisms and Immunotherapy.

Baecher-Allan C, Kaskow BJ, Weiner HL.

Neuron. 2018 Feb 21;97(4):742-768. doi: 10.1016/j.neuron.2018.01.021. Review.

4.

Effector T Cells in Multiple Sclerosis.

Kaskow BJ, Baecher-Allan C.

Cold Spring Harb Perspect Med. 2018 Apr 2;8(4). pii: a029025. doi: 10.1101/cshperspect.a029025. Review.

PMID:
29358315
5.

Optimizing human Treg immunotherapy by Treg subset selection and E-selectin ligand expression.

Donnelly C, Dykstra B, Mondal N, Huang J, Kaskow BJ, Griffin R, Sackstein R, Baecher-Allan C.

Sci Rep. 2018 Jan 11;8(1):420. doi: 10.1038/s41598-017-17981-z.

6.

Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6.

Bhela S, Kempsell C, Manohar M, Dominguez-Villar M, Griffin R, Bhatt P, Kivisakk-Webb P, Fuhlbrigge R, Kupper T, Weiner H, Baecher-Allan C.

J Immunol. 2015 Mar 1;194(5):2180-9. doi: 10.4049/jimmunol.1303257. Epub 2015 Jan 30.

7.

Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells.

Hu X, Kim H, Raj T, Brennan PJ, Trynka G, Teslovich N, Slowikowski K, Chen WM, Onengut S, Baecher-Allan C, De Jager PL, Rich SS, Stranger BE, Brenner MB, Raychaudhuri S.

PLoS Genet. 2014 Jun 26;10(6):e1004404. doi: 10.1371/journal.pgen.1004404. eCollection 2014 Jun.

8.

Application of user-guided automated cytometric data analysis to large-scale immunoprofiling of invariant natural killer T cells.

Hu X, Kim H, Brennan PJ, Han B, Baecher-Allan CM, De Jager PL, Brenner MB, Raychaudhuri S.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19030-5. doi: 10.1073/pnas.1318322110. Epub 2013 Nov 4.

9.

Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells.

Seneschal J, Clark RA, Gehad A, Baecher-Allan CM, Kupper TS.

Immunity. 2012 May 25;36(5):873-84. doi: 10.1016/j.immuni.2012.03.018. Epub 2012 May 3.

10.

Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease.

Dominguez-Villar M, Baecher-Allan CM, Hafler DA.

Nat Med. 2011 Jun;17(6):673-5. doi: 10.1038/nm.2389. Epub 2011 May 3.

11.

CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.

Baecher-Allan CM, Costantino CM, Cvetanovich GL, Ashley CW, Beriou G, Dominguez-Villar M, Hafler DA.

J Immunol. 2011 Mar 15;186(6):3317-26. doi: 10.4049/jimmunol.1002502. Epub 2011 Feb 7.

12.

Droplet-based microfluidic platforms for single T cell secretion analysis of IL-10 cytokine.

Konry T, Dominguez-Villar M, Baecher-Allan C, Hafler DA, Yarmush ML.

Biosens Bioelectron. 2011 Jan 15;26(5):2707-10. doi: 10.1016/j.bios.2010.09.006. Epub 2010 Sep 15.

13.

TGF-beta induces IL-9 production from human Th17 cells.

Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T, Elyaman W, Khoury SJ, Kuchroo VK, Baecher-Allan C, Hafler DA.

J Immunol. 2010 Jul 1;185(1):46-54. doi: 10.4049/jimmunol.1000356. Epub 2010 May 24.

14.

Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B.

Ashley CW, Baecher-Allan C.

J Immunol. 2009 Oct 15;183(8):4843-7. doi: 10.4049/jimmunol.0900845.

15.

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells.

Ilan Y, Zigmond E, Lalazar G, Dembinsky A, Ben Ya'acov A, Hemed N, Kasis I, Axelrod E, Zolotarov L, Klein A, El Haj M, Gandhi R, Baecher-Allan C, Wu H, Murugaiyan G, Kivisakk P, Farez MF, Quintana FJ, Khoury SJ, Weiner HL.

J Clin Immunol. 2010 Jan;30(1):167-77. doi: 10.1007/s10875-009-9323-7. Epub 2009 Sep 16.

16.

Automated high-dimensional flow cytometric data analysis.

Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler DA, De Jager PL, Mesirov JP.

Proc Natl Acad Sci U S A. 2009 May 26;106(21):8519-24. doi: 10.1073/pnas.0903028106. Epub 2009 May 14.

17.

The role of the CD58 locus in multiple sclerosis.

De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu X, Ashley CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, Stewart GJ, Palotie A, Peltonen L, Dubois B, Haines JL, Weiner HL, Compston A, Hauser SL, Daly MJ, Reich D, Oksenberg JR, Hafler DA.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5264-9. doi: 10.1073/pnas.0813310106. Epub 2009 Feb 23.

18.

IL-17-producing human peripheral regulatory T cells retain suppressive function.

Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA.

Blood. 2009 Apr 30;113(18):4240-9. doi: 10.1182/blood-2008-10-183251. Epub 2009 Jan 26.

19.

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.

Maier LM, Anderson DE, Severson CA, Baecher-Allan C, Healy B, Liu DV, Wittrup KD, De Jager PL, Hafler DA.

J Immunol. 2009 Feb 1;182(3):1541-7.

20.

Multiple sclerosis and regulatory T cells.

Costantino CM, Baecher-Allan C, Hafler DA.

J Clin Immunol. 2008 Nov;28(6):697-706. doi: 10.1007/s10875-008-9236-x. Epub 2008 Sep 2. Review.

21.

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.

Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA.

Nature. 2008 Jul 17;454(7202):350-2. doi: 10.1038/nature07021. Epub 2008 May 11.

22.

The purification and functional analysis of human CD4+CD25high regulatory T cells.

Baecher-Allan CM, Hafler DA.

Curr Protoc Immunol. 2006 May;Chapter 7:Unit 7.4B. doi: 10.1002/0471142735.im0704bs72.

PMID:
18432975
23.

Human regulatory T cells and autoimmunity.

Costantino CM, Baecher-Allan CM, Hafler DA.

Eur J Immunol. 2008 Apr;38(4):921-4. doi: 10.1002/eji.200738104. Review.

24.

Up-regulation of gene related to anergy in lymphocytes is associated with Notch-mediated human T cell suppression.

Kostianovsky AM, Maier LM, Baecher-Allan C, Anderson AC, Anderson DE.

J Immunol. 2007 May 15;178(10):6158-63.

25.

Human regulatory T cells and their role in autoimmune disease.

Baecher-Allan C, Hafler DA.

Immunol Rev. 2006 Aug;212:203-16. Review.

PMID:
16903916
26.

Human CD25high Tregs: isolation by beads versus by FACS sorting.

Baecher-Allan C.

Clin Immunol. 2006 Aug;120(2):234-5. Epub 2006 Jun 8. No abstract available.

PMID:
16762596
27.

MHC class II expression identifies functionally distinct human regulatory T cells.

Baecher-Allan C, Wolf E, Hafler DA.

J Immunol. 2006 Apr 15;176(8):4622-31.

28.

Immune regulation in tumor-bearing hosts.

Baecher-Allan C, Anderson DE.

Curr Opin Immunol. 2006 Apr;18(2):214-9. Epub 2006 Feb 7. Review.

PMID:
16464567
29.

Regulatory cells and human cancer.

Baecher-Allan C, Anderson DE.

Semin Cancer Biol. 2006 Apr;16(2):98-105. Epub 2005 Dec 27. Review.

PMID:
16378733
30.

Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells.

Baecher-Allan CM, Hafler DA.

Clin Immunol. 2005 Nov;117(2):192; discussion 193. No abstract available.

PMID:
16214081
31.

Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells.

Baecher-Allan C, Wolf E, Hafler DA.

Clin Immunol. 2005 Apr;115(1):10-8.

PMID:
15870015
32.

Multiple sclerosis.

Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C.

Immunol Rev. 2005 Apr;204:208-31. Review.

PMID:
15790361
33.

Suppressor T cells in human diseases.

Baecher-Allan C, Hafler DA.

J Exp Med. 2004 Aug 2;200(3):273-6. Epub 2004 Jul 26.

34.

T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.

Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris RA, Hafler DA, Kuchroo VK, Olsson T, Piehl F, Wallström E.

J Immunol. 2004 Jun 1;172(11):7169-76.

35.

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA.

J Exp Med. 2004 Apr 5;199(7):971-9.

36.

Human CD4+CD25+ regulatory T cells.

Baecher-Allan C, Viglietta V, Hafler DA.

Semin Immunol. 2004 Apr;16(2):89-98. Review.

PMID:
15036232
37.

CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA.

Novartis Found Symp. 2003;252:67-88; discussion 88-91, 106-14.

PMID:
14609213
38.

Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.

Cao D, Malmström V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C.

Eur J Immunol. 2003 Jan;33(1):215-23.

39.

Inhibition of human CD4(+)CD25(+high) regulatory T cell function.

Baecher-Allan C, Viglietta V, Hafler DA.

J Immunol. 2002 Dec 1;169(11):6210-7.

40.

Mapping susceptibility genes for the induction of pulmonary fibrosis in mice.

Barth RK, Hanchett LA, Baecher-Allan CM.

Chest. 2002 Mar;121(3 Suppl):21S. No abstract available.

PMID:
11893659
41.

CD4+CD25high regulatory cells in human peripheral blood.

Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA.

J Immunol. 2001 Aug 1;167(3):1245-53.

42.

Recombinant polyclonal antibody libraries.

Sharon J, Sarantopoulos S, Den W, Kao CY, Baecher-Allan CM, Santora KE, Sompuram SR, Petersen-Mahrt S, Williams BR.

Comb Chem High Throughput Screen. 2000 Jun;3(3):185-96. Review.

PMID:
10903378
43.

Serpins identified as cell growth inhibitors in human plasma.

Yao J, Baecher-Allan CM, Sharon J.

Mol Cell Biol Res Commun. 2000 Feb;3(2):76-81.

PMID:
10775503
44.

Generation of a polyclonal Fab phage display library to the protozoan parasite Cryptosporidium parvum.

Baecher-Allan CM, Santora K, Sarantopoulos S, Den W, Sompuram SR, Sharon J, Cevallos AM, Bhat N, Ward H.

Comb Chem High Throughput Screen. 1999 Dec;2(6):319-25.

PMID:
10644857
45.

Cell-specific gene expression reveals changes in epithelial cell populations after bleomycin treatment.

Daly HE, Baecher-Allan CM, Paxhia AT, Ryan RM, Barth RK, Finkelstein JN.

Lab Invest. 1998 Apr;78(4):393-400.

PMID:
9564884
46.

Elimination of T-cell-receptor beta-chain diversity in transgenic mice restricts antigen-specific but not alloreactive responses.

O'Brien DP, Baecher-Allan CM, Burns RP Jr, Shastri N, Barth RK.

Immunology. 1997 Jul;91(3):375-82.

47.

Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.

Daly HE, Baecher-Allan CM, Barth RK, D'Angio CT, Finkelstein JN.

Toxicol Appl Pharmacol. 1997 Feb;142(2):303-10.

PMID:
9070353
48.
49.

Differential epitope expression of Ly-48 (mouse leukosialin).

Baecher-Allan CM, Kemp JD, Dorfman KS, Barth RK, Frelinger JG.

Immunogenetics. 1993;37(3):183-92.

PMID:
7678405

Supplemental Content

Loading ...
Support Center